The genotype analysis of the hepatitis C virus in Heilongjiang Province, China

Xue-Di Cheng1,2, Hua-Feng Xu3, Feng Wei2

  • 1Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, Shandong.

Medicine
|May 5, 2021
PubMed

Insights

Hepatitis C virus (HCV) genotyping in Heilongjiang, China, revealed a high 23% recombination rate. This study identified novel 2a/1b recombination patterns, crucial for understanding HCV evolution and treatment strategies.

Area of Science:

  • Virology
  • Public Health
  • Bioinformatics

Background:

  • Hepatitis C virus (HCV) infection presents a significant global health challenge.
  • Accurate HCV genotyping is essential for effective treatment planning.
  • Previous research has not assessed HCV genotypes and subtypes in China's Heilongjiang Province.

Purpose of the Study:

  • To determine the genotypes and subtypes of HCV in Heilongjiang Province.
  • To perform phylogenetic analysis of HCV strains in the region.
  • To investigate the prevalence of HCV recombination in this population.

Main Methods:

  • Amplification of three HCV genome regions (5'UTR, E1, NS5B) from 30 patient samples.
  • Bioinformatic analysis of the amplified genetic material.
  • Phylogenetic analysis to determine viral genotypes and subtypes.

Main Results:

  • HCV genotypes 2a and 1b were identified.
  • A high recombination rate of 23% was observed among the patients.
  • Specific recombination patterns, including novel 2a/1b combinations across the analyzed regions, were documented.

Conclusions:

  • Heilongjiang Province exhibits a higher HCV recombination rate than previously reported.
  • The identified recombination patterns, particularly 2a/1b, offer new insights into HCV evolution.
  • This research provides critical data for understanding HCV epidemiology and guiding clinical management in the region.